誉衡药业：部分董事及高级管理人员减持计划实施完毕

Group 1 - The company announced that the share reduction plan by its executives has been completed [1] - Vice General Managers Li Runbao and Wang Xiaohang each reduced their holdings by 587,500 shares, accounting for 0.03% of the company's total shares [1] - Board Secretary and Vice General Manager Liu Yueyin reduced his holdings by 259,600 shares, accounting for 0.01% of the company's total shares [1] Group 2 - The reduction price range for the shares was between 2.9 yuan and 2.92 yuan per share [1] - After the reduction, Li Runbao and Wang Xiaohang each hold 1,762,500 shares, representing 0.08% of the total share capital [1] - Liu Yueyin now holds 779,000 shares, which is 0.03% of the total share capital [1]